This week, we are seeing a clear shift away from generic AI hype toward highly customized clinical models and the hard realities of public trust. It is becoming obvious that off-the-shelf algorithms cannot handle high-stakes medicine without deep clinical context.
🔹 Mayo Clinic and Microsoft build frontier AI — Mayo Clinic and Microsoft are doubling down on custom AI models, betting that generic algorithms cannot handle the high-stakes reality of clinical decision-making.
My take: When I was building Yesil Health, we quickly realized that generic LLMs hallucinate clinical details. Building custom, medically-tuned frontier models is the only safe path forward, even if it is incredibly capital-intensive.
🔹 Palantir’s NHS Data Access Sparks Trust Crisis — A quiet shift in NHS data access permissions has shattered public trust and put a £330 million technology contract on life support.
My take: This is a massive warning for builders. You can have the best predictive analytics in the world, but if patients and clinicians do not trust how you handle their data, your platform will never see the light of day in a real clinic.
🔹 AI Designs One Vaccine for All Coronaviruses — A tiny trial of an AI-designed vaccine suggests we might finally stop chasing viral mutations and start anticipating them.
My take: Using AI to find conserved viral regions is a brilliant application of machine learning. It shifts us from reactive booster development to proactive, broad-spectrum defense.
🔹 Hybrid AI predicts the next dental procedure — A new study reveals that advanced language models fail at predicting dental treatments unless they are paired with basic, old-school statistics.
My take: This is a great reality check for developers. Do not use an expensive LLM where a simple regression model or basic clinical decision tree does the job better and cheaper.
🔹 AI Vaccine Targets Every Major Coronavirus Strain — A needle-free vaccine designed by artificial intelligence has cleared its first human trial, signaling a shift from reactive booster shots to proactive pandemic defense.
My take: If you are seeing patients next week, this is the kind of research that shows how computational biology will change preventative medicine in the next decade.
